Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 139

    Bayer can absorb Roundup costs of 5 billion euros, but not 20 billion - Moodys

    Bayer can absorb Roundup costs of 5 billion euros, but not 20 billion - Moody's

    Medical Dialogues Bureau1 May 2019 9:04 AM IST
    BERLIN: Bayer could absorb litigation costs of up to 5 billion euros ($5.59 billion) to settle ongoing lawsuits linked to its Monsanto weed-killer...
    CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India

    CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India

    Farhat Nasim30 April 2019 10:15 AM IST
    "SIFI's innovative IOLs (Intraocular lenses) have been approved by the Indian Central Drugs Standards Control Organisation(CDSCO) (Directorate General...
    Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension

    Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension

    Farhat Nasim30 April 2019 10:00 AM IST
    Cipla's Ambrisentan tablets 5 mg and 10 mg is AB-rated generic therapeutic equivalent version of Gilead Sciences Inc's Letairis.New Delhi: Drug major...
    Biocon Q4 profit up 64 percent at Rs 214 crore

    Biocon Q4 profit up 64 percent at Rs 214 crore

    Garima30 April 2019 9:45 AM IST
    Bengaluru: Biotechnology major, Biocon Ltd recently announced its consolidated financial results for the fourth quarter and fiscal year ended March...
    Aurobindo Pharma gets MoEFCC nod for Andhra Pradesh plant expansion

    Aurobindo Pharma gets MoEFCC nod for Andhra Pradesh plant expansion

    Farhat Nasim30 April 2019 9:30 AM IST
    The Rs 250 crore expansion project by Aurobindo Pharma is expected to generate jobs for 600 people directly and 120 indirectly.Hyderabad: The Rs...
    GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus

    GSK gets USFDA nod for Benlysta to treat pediatric patients with lupus

    Medical Dialogues Bureau30 April 2019 9:15 AM IST
    New Delhi: GlaxoSmithKline (GSK) has won the US Food and Drug Administration's (USFDA) approval for its Benlysta (belimumab) intravenous (IV) infusion...
    Using AI to detect mental health disorders likely to be counterproductive

    Using AI to detect mental health disorders likely to be counterproductive

    Medical Dialogues Bureau30 April 2019 9:00 AM IST
    AI-based vocal analytics may allow patients to detect the disease at home by just speaking into a smartphone application, eliminating the need to be...
    Presence of Formaldehyde in JnJ baby shampoo; company junks Rajasthan report

    Presence of Formaldehyde in JnJ baby shampoo; company junks Rajasthan report

    Meghna A Singhania29 April 2019 10:00 AM IST
    Based on the report of the Drug Testing Laboratory in Jaipur, the National Commission for Protection of Child Rights (NCPCR) has written to the chief...
    Dr Reddys, Cipla arm recall drugs in US; includes 7.8 lakh vials of Testosterone Cypionate injection

    Dr Reddys, Cipla arm recall drugs in US; includes 7.8 lakh vials of Testosterone Cypionate injection

    Farhat Nasim29 April 2019 9:45 AM IST
    Besides, InvaGen Pharmaceuticals Inc, a subsidiary of Mumbai-based drug maker Cipla, is recalling over 7.8 lakh vials of Testosterone Cypionate...
    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer

    Farhat Nasim29 April 2019 9:35 AM IST
    The positive CHMP opinion of TALZENNA follows the medicine's approval by the U.S. Food and Drug Administration (FDA) in October 2018.New Delhi:...
    ISIC to set up laboratory to test quality of indigenous implants

    ISIC to set up laboratory to test quality of indigenous implants

    Garima29 April 2019 9:30 AM IST
    ISIC will collaborate with premier institutions such as IIT to develop the laboratory.New Delhi: The Indian Spinal Injuries Centre (ISIC) will set up...
    USFDA approves perfusion device Xvivo Perfusion System for lung transplants

    USFDA approves perfusion device Xvivo Perfusion System for lung transplants

    Medical Dialogues Bureau29 April 2019 9:00 AM IST
    The Xvivo Perfusion System works by allowing marginal quality lungs that initially failed to meet standard transplantation models to be ventilated,...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Unichem Labs net loss narrows to Rs 22 crore in September quarter

    Unichem Labs net loss narrows to Rs 22 crore in September quarter

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Genomica, HuaSin Science complete first CLART diagnostic equipment for early diagnosis of cancer in China

    Genomica, HuaSin Science complete first CLART diagnostic equipment for early diagnosis of cancer in...

    Transasia Bio-Medicals names Medtronic biz director Ravi Kaushik as new CEO

    Transasia Bio-Medicals names Medtronic biz director Ravi Kaushik as new CEO

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok